It is FDA-approved under two brand names: Wegovy for chronic weight management and Ozempic for type 2 diabetes
We provide recommendations for use of specific obesity pharmacotherapies with proven benefit in specific subpopulations atherosclerotic cardiovascular disease, heart failure with preserved ejection fraction, metabolic dysfunctionassociated steatohepatitis, prediabetes, type 2 diabetes, obstructive sleep apnea, osteoarthritis and for those with certain specific monogenic causes of obesity
From the AFP Editors Management of patients with type 2 diabetes mellitus is evolving
Because tirzepatide works through an additional receptor (GIP) that semaglutide doesn't target, some people who respond poorly to semaglutide may respond to tirzepatide's dual mechanism
A carnitina sintetizada nos rins, fgado e crebro, favorece o controle de triglicerdeos no sangue e faz parte da transformao da gordura das clulas em energia
Generic competition upon patent expiry in 2031 will erode market share and pricing power
